(Q51013350)

27 March 2018

title

Apolipoprotein B independently predicts progression of very-low-level albuminuria in insulin-dependent diabetes mellitus. (English)

1 reference

27 March 2018

1 reference

Watts GF

1

1 reference

27 March 2018

Powrie JK

series ordinal

2

1 reference

27 March 2018

O'Brien SF

series ordinal

3

1 reference

27 March 2018

Shaw KM

series ordinal

4

1 reference

27 March 2018

publication date

1 September 1996

1 reference

27 March 2018

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

27 March 2018

volume

45

1 reference

27 March 2018

issue

9

1 reference

27 March 2018

page(s)

1101-1107

1 reference

27 March 2018

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

1 reference

Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Risk factors for development of microalbuminuria in insulin dependent diabetic patients: a cohort study. Microalbuminuria Collaborative Study Group, United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

7 January 2021

Lipids and the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Atherogenic lipoproteins: mediators of glomerular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Serum Lipids and Lipoproteins in Insulin-dependent Diabetic Patients with Persistent Microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Lipoprotein disorders in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Recent progress in understanding apolipoprotein B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Long-term variation of urinary albumin excretion in insulin-dependent diabetes mellitus: some practical recommendations for monitoring microalbuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Microalbuminuria as a predictor of clinical diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Prediction of creatinine clearance from serum creatinine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Lipoprotein (a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Serum sialic acid as an indicator of change in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Elevated serum sialic acid concentration in NIDDM and its relationship to blood pressure and retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Lipid abnormalities in insulin-dependent diabetic patients with albuminuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Lipoprotein(a) and diabetes. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Lack of familial predisposition to cardiovascular disease in type 1 (insulin-dependent) diabetic patients with nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Progression of proteinuria in type 1 and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

The Prevalence of Hypercholesterolaemia and its Relationship With Albuminuria in Insulin-dependent Diabetic Patients: An Epidemiological Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Calculated low-density lipoprotein cholesterol should not be used for management of lipoprotein abnormalities in patients with diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Localization of apolipoprotein(a) and B-100 in various renal diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Specific thromboxane synthetase inhibition and albumin excretion rate in insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Non-enzymatic glycosylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

The link between hyperglycaemia and diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Lipoprotein glycation and its metabolic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Advanced glycosylation end products in patients with diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

Cholesterol-lowering therapy may retard the progression of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990009-8

10.1016/S0026-0495(96)90009-8

7 January 2021

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018